SN
BMRN icon

Sittner & Nelson’s BioMarin Pharmaceuticals BMRN Stock Holding History

Sittner & Nelson’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$153K Hold
2,700
– – 0.06% 191
2025
Q4 		$157K Sell
2,700
-100
-4% -$5.44K 0.06% 183
2025
Q3 		$152K Sell
2,800
-300
-10% -$17.2K 0.06% 172
2025
Q2 		$170K Buy
3,100
+200
+7% +$11.8K 0.07% 155
2025
Q1 		$205K Hold
2,900
– – 0.09% 137
2024
Q4 		$191K Hold
2,900
– – 0.08% 133
2024
Q3 		$204K Sell
2,900
-100
-3% -$8.36K 0.09% 132
2024
Q2 		$247K Hold
3,000
– – 0.12% 102
2024
Q1 		$262K Buy
+3,000
New +$269K 0.13% 101
2023
Q3 		– Sell
-45
Closed -$3.9K – 468
2023
Q2 		$3.9K Buy
+45
New +$4.24K ﹤0.01% 416

Other funds holding BMRN

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return